// App-Quantinova.ai

: Oral corticosteroid (OCS)-sparing effect of tralokinumab in severe, uncontrolled asthma: the TROPOS study

Researchers

Presenter

  • William Busse

Principal Investigators

  • Guy Brusselle

  • Stephanie Korn

  • Piotr Kuna

  • Antoine Magnan

  • David Cohen

  • Karin Bowen

  • Teresa Piechowiak

  • Millie Wang

  • Gene Colice

Medical Centers

  • University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States

  • Hematology, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium

  • Pulmonary Department, Mainz University Hospital, Mainz, Germany

  • Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland,

  • L'institut du thorax INSERM CNRS University of Nantes CHU Nantes Nantes France

  • AstraZeneca Gaithersburg, Gaithersburg, United States of America

  • AstraZeneca, Mississauga, Canada

Locations

  • United States

  • Belgium

  • Germany

  • Poland

  • France

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • CAT-354

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved